ASSOCIATION OF ADHERENCE AND TREATMENT INTENSITY OF LIPID-LOWERING THERAPY WITH CARDIOVASCULAR OUTCOMES AND ALL-CAUSE MORTALITY IN POST-MI PATIENTS IN GERMANY.

被引：0
|
作者：
Sidelnikov, E. [1 ]
Hatz, M. [2 ]
Khachatryan, A. [3 ]
Monga, B. B. [4 ]
Ahrens, I [5 ]
机构：
[1] Amgen Europe GmbH, Rotkreuz, ZG, Switzerland
[2] Amgen Inc, Munich, Germany
[3] Certara Evidence & Access, London, England
[4] Elsevier Hlth Analyt, Strasbourg 67, France
[5] Augustinerinnen Hosp, Cologne, Germany
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV86
引用
收藏
页码：S557 / S557
页数：1
相关论文
共 44 条
  • [1] Association of adherence and treatment intensity of lipid-lowering therapy with cardiovascular outcomes and all-cause mortality in very high-risk patients in Germany
    Khachatryan, A.
    Monga, B.
    Sidelnikov, E.
    Hatz, M.
    Ahrens, I.
    EUROPEAN HEART JOURNAL, 2019, 40 : 252 - 252
  • [2] Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany
    Ingo Ahrens
    Artak Khachatryan
    Bondo Monga
    Eugen Dornstauder
    Eduard Sidelnikov
    Advances in Therapy, 2021, 38 : 2532 - 2541
  • [3] Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany
    Ahrens, Ingo
    Khachatryan, Artak
    Monga, Bondo
    Dornstauder, Eugen
    Sidelnikov, Eduard
    ADVANCES IN THERAPY, 2021, 38 (05) : 2532 - 2541
  • [4] Lipid-lowering therapy and mortality post-MI: is it just about the LDL?
    Halcox, Julian P.
    Currie, Craig J.
    HEART, 2014, 100 (11) : 825 - 826
  • [5] Effect of overall lifestyle on the all-cause mortality and cardiovascular disease death in dyslipidemia patients with or without lipid-lowering therapy: a cohort study
    Qian Wang
    Dong Pang
    Hui Wang
    BMC Cardiovascular Disorders, 23
  • [6] Effect of overall lifestyle on the all-cause mortality and cardiovascular disease death in dyslipidemia patients with or without lipid-lowering therapy: a cohort study
    Wang, Qian
    Pang, Dong
    Wang, Hui
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [7] Intensity of and Adherence to Lipid-Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease
    Mazhar, Faizan
    Hjemdahl, Paul
    Clase, Catherine M.
    Johnell, Kristina
    Jernberg, Tomas
    Sjolander, Arvid
    Carrero, Juan Jesus
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (14):
  • [8] High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality
    Danchin, Nicolas
    Simon, Tabassome
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (05) : 328 - 330
  • [9] TRENDS OF ALL-CAUSE MORTALITY AND CARDIOVASCULAR MORTALITY IN CANCER PATIENTS POST RADIATION THERAPY
    Upreti, Prakash
    Baral, Nischit
    Phuyal, Prabin
    Patel, Brijesh D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2591 - 2591
  • [10] Association between triglyceride with all-cause mortality and cardiovascular outcomes in heart failure patients
    Ren, Q. W.
    Chan, H. C.
    Tsang, T. W.
    Tse, Y. K.
    Wu, M. Z.
    Xu, X.
    Yiu, K. H.
    EUROPEAN HEART JOURNAL, 2023, 44
12345